(Tyr0)-C-Peptide (dog)

CAS No. 101135-67-5

(Tyr0)-C-Peptide (dog)( ——— )

Catalog No. M40119 CAS No. 101135-67-5

(Tyr0)-C-Peptide (dog) is a peptide.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (Tyr0)-C-Peptide (dog)
  • Note
    Research use only, not for human use.
  • Brief Description
    (Tyr0)-C-Peptide (dog) is a peptide.
  • Description
    (Tyr0)-C-Peptide (dog) is a peptide.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    101135-67-5
  • Formula Weight
    3337.72
  • Molecular Formula
    C146H234N38O51
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Asakawa D, et al. Influences of proline and cysteine residues on fragment yield in matrix-assisted laser desorption/ionization in-source decay mass spectrometry. J Am Soc Mass Spectrom. 2014 Jun;25(6):1040-8. ?
molnova catalog
related products
  • Lyticase

    Lyticase, produced by a submerged culture of Arthrobacter luteus, is an enzyme preparation which effectively lyses cell walls of viable yeast cells. An essential enzyme responsible for lysis of viable yeast cells in this preparation is b-1, 3-glucan laminaripentaohydrolase.

  • 2-Methylsuccinic aci...

    Methylsuccinic acid is a normal metabolite found in human fluids. Increased urinary levels of Methylsuccinic acid (together with ethylmalonic acid) are the main biochemical measurable features in ethylmalonic encephalopathy a rare metabolic disorder with an autosomal recessive mode of inheritance that is clinically characterized by neuromotor delay hyperlactic acidemia recurrent petechiae orthostatic acrocyanosis and chronic diarrhea.

  • Beclobrate

    Beclobrate (Sgd 24774) is a novel orally available fibric acid derivative that has shown significant lipid and cholesterol-lowering activity in rodents and may be used in the study of primary hyperlipoproteinemia.